1970, District of Columbia; 1973, U.S. Supreme Court; 1982, U.S. Court of Appeals, Tenth Circuit; 1984, U.S. Court of Appeals, Eleventh Circuit; 1985, U.S. Court of Appeals for the Federal Circuit; 1988, U.S. Court of Appeals, Fifth, Sixth and Ninth Circu
Harvard University, J.D., summa cum laude, 1969
Law School Graduation Year
Haverford College, B.A., summa cum laude, 1964; Oxford University, Oxford, England, B.A., 1st Class,
The District of Columbia Bar; American Bar Association (Member, Section of Corporation, Banking and Business Law).
Phi Beta Kappa. Rhodes Scholar. President, Harvard Law Review, 1968-1969, Volume 82. Ranked as the 8th Best Lawyer in Washington, D.C. by Washingtonian Magazine, April 2002. Author: Drug Labeling and Products Liability: The Role of the Food and Drug Administration, 41 Food Drug Cosmetic L.J. 233 (1986); Regulation Through Private Litigation, 47 Food and Drug L.J. 437 (1992); Problems of Outcomes Studies: Data Access, Conflicts of Interest, and Peer Review, J. Ass'n of Food & Drug Officials, Mar. 1994 at 36; Unapproved Uses of Drugs: An Analysis and Some Proposals, 49 Food and Drug L.J. 4 (1994); Corporate Regulatory Crimes and the Sentencing Revolution, Business Crimes Bull., Apr. 1994, 8; Taking Steps Against Corporate Crime: An Approach After Caremark, Bus. Crimes Bull., Jan., 1997; The WLF Case Thus Far: Not With a Bang But a Whimper, 55 Food & Drug L.J. 477 (2000); Challenging Food and Drug Administration Interpretations of the Federal Food, Drug, and Cosmetic Act, 58 Food & Drug L.J. 1 (2003); Internal Investigations, Nat'l L.J. 7/28/03 at 28; Co-Editor, Fundamentals of Law and Regulation, (FDLI 1997). Adjunct Professor, Georgetown University Law Center, 1987-1992; 1995-1996. Law Clerk to Justice Brennan, U.S. Supreme Court, 1969-1970. Senior Lecturer, Law Development Center, Kampala, Uganda, 1970-1971. Senior Member, Office of Energy Policy and Planning, Executive Office of the President, 1977. Chief Counsel, U.S. Food and Drug Administration, 1977-1979. Member, Committee on Priority Mechanisms, National Academy of Sciences, 1980-1983. Member, Committee on Contraceptive Development, Institute of Medicine, 1987-1990. Member, Advisory Panel on Strategies for Medical Technology Assessment, U.S. Congressional Office of Technology Assessment, 1980-1981. Chairman, Editorial Advisory Board, Food and Drug L.J., 1985-1986; Member, 1981-1988, 1992-1996. Chairman, Board of Editors, Business Crimes Bulletin, 1996—. Columnist on Business Crime, National Law Journal, 1998—. Member, Board of